| VNDA Snapshot | |
|---|---|
| Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia. | |
| VALUATION DATA | |
| Market Capitalization | $276,180,000 | Price to Sales | 1.00 |
| Earnings per Share | $0.0400 |
| PE Ratio | 120 |
| PRICE DATA | |
| Most Recent Close | $4.8000 |
| 52 Week High | $1.231 |
| 52 Week Low | $0.436 |
| 50-Day Moving Average | $0.586 |
| 200-Day Moving Average | $12.91 |
| All data are from Alpha Vantage as of today. For more infomation on VNDA see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search